On Friday, Murphy Oil Corporation (NYSE:MUR)’s shares declined -1.18% to $32.56.
The Board of Directors of Murphy Oil Corporation (MUR) declared a quarterly cash dividend on the Common Stock of Murphy Oil Corporation of $0.35 per share, or $1.40 per share on an annualized basis. The dividend is payable September 1, 2015 to holders of record August 17, 2015.
Murphy Oil Corporation operates as an oil and gas exploration and production company worldwide. It explores for and produces crude oil, natural gas, and natural gas liquids. The company was formerly known as Murphy Corporation and changed its name to Murphy Oil Corporation in 1964. Murphy Oil Corporation was founded in 1950 and is headquartered in El Dorado, Arkansas.
FibroGen Inc (NASDAQ:FGEN)’s shares gained 16.77% to $25.90.
FibroGen Inc (FGEN) was a big mover last session with its shares rising over 8% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $17.36 to $20.59.
This research-based biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Friday’s jump is encouraging though, so make sure to keep a close watch on this firm in the near future.
FibroGen, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs. It is developing roxadustat, or FG-4592, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases (HIF-PHs) that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; FG-3019, a monoclonal antibody in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis; and FG-5200 for the treatment of corneal blindness resulting from partial thickness corneal damage.
At the end of Friday’s trade, Anthem Inc (NYSE:ANTM)‘s shares dipped -0.32% to $149.30.
Anthem, Inc. (ANTM) declared that second quarter 2015 net income was $859.1 million, or $3.13 per share. These results comprised of net gains of $0.03 per share. Net income in the second quarter of 2014 was $731.1 million, or $2.56 per share.
Not taking into account the items noted in each period, adjusted net income was $3.10 per share in the second quarter of 2015, an enhance of 21.1 percent contrast with adjusted net income of $2.56 per share in the preceding year quarter (refer to the GAAP reconciliation table for a reconciliation to the most directly comparable measure calculated in accordance with U.S. generally accepted accounting principles, or “GAAP”).
Anthem, Inc., through its auxiliaries, operates as a health benefits company in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets.
Electronic Arts Inc. (NASDAQ:EA), ended its Friday’s trading session with -0.76% loss, and closed at $72.82.
Electronic Arts Inc. (EA) launched EA SPORTS™ Rory McIlroy PGA TOUR® for Xbox One®, the all-in-one games and entertainment system from Microsoft and PlayStation®4 computer entertainment system. The power of Frostbite™ 3, in addition to customizable gameplay styles and numerous ways to play all combine to truly deliver Golf Without Limits.
Electronic Arts Inc. develops, markets, publishes, and distributes game software content and online services for video game consoles, Internet-connected consoles, personal computers, mobile phones, and tablets worldwide. The company operates through EA Studios, EA Mobile, and Maxis divisions. It develops and publishes digital interactive entertainment games primarily under the The Sims, Madden NFL, EA SPORTS FIFA, Battlefield, FIFA Soccer, Need for Speed, Dragon Age, and Plants vs. Zombies brand names.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
